Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Q: The news release does not mention costs. While a new therapy may not have an established price, the release could have stated “no price is available for this drug.” What would be even better is some context for what women suffering from postpartum pay typically for counseling and medications. The release notes that  there was a reduction in depressive symptoms of 17 points for those on the drug, and 12.8 for those in the placebo group based on the Hamilton Depression Rating Scale. The absolute reduction in the rating scale is given for each group. This information would have been much more helpful if the release also clarified the magnitude of the scale and whether a 4.2-point difference is clinically meaningful. The release contains one somewhat vague sentence on harms. The most common (≥10% of subjects) adverse events following during brexanolone injection administration were headache, dizziness and somnolence. Readers would also be interested in details on whether the drug is safe for nursing infants. That’s not mentioned. The double-blinded randomized trials are described in detail and readers are able to judge the quality of the evidence. The published study includes an important limitation of the research that’s not mentioned in the release: The trials assessed women for only 30 days; the effects of the treatment beyond 30 days are “unknown.” There is no disease mongering. The release explains how common postpartum depression is worldwide. The release notes that Sage Therapeutics funded the research. Sage Therapeutics is the developer of brexanolone injection and sponsor of the trials. A New Drug Application is currently under review by the FDA and brexanolone injection has been granted Breakthrough Therapy Designation. The FDA has assigned a Prescription Drug User Fee Act target date of December 19, 2018. What the release doesn’t tell us is that both quoted researchers disclosed financial ties with Sage Therapeutics. This information was included in the studies published in the Lancet. SM-B reports personal fees from MedScape and grants from Sage Therapeutics, awarded to the University of North Carolina … DRR reports personal fees and has stock options in Sage Therapeutics…. The release mentions that women currently can receive antidepressants for postpartum depression, but that the new drug being studied goes to work relieving symptoms faster than traditional antidepressants — days rather than weeks. The release notes that the drug is currently under FDA review, with a decision on its approval expected by the end of the year. The release notes that the new drug would be a novel treatment for postpartum depression, if approved. There is no unjustifiable language.

A: Newly Published Results Show Investigational Treatment Brexanolone Consistently Reduced Depressive Symptoms Across Three Postpartum Depression Trials, Supporting Submission for FDA Approval
****
Q: "During the first Democratic presidential debate in October 2015, Hillary Clinton proclaimed, ""We’ve got to be committed to getting every child to live up to his or her God-given potential."" Cynthia Meyer, who took up the post of deputy press secretary for Texas Attorney General Ken Paxton in early 2015, fired back with a tweet, ""Would help if they had the chance to be born."" About a month later, in the next Democratic debate Nov. 14, 2015, the episode was repeated. Clinton echoed her earlier comment, again declaring, ""Every single one of our children deserves the chance to live up to his or her God-given potential."" This time, Meyer responded by tweeting, ""More black babies are aborted in NYC than born,"" followed by the hashtag #blacklivesmatter. NYC meaning the city of New York. The pair of exchanges elicited a strong sense of deja vu, but Meyer’s second tweet raised a more specific question about abortion rates among black women in the Big Apple: Are there more abortions by black women in NYC than births? To our inquiry, over email Meyer said her responses were an effort to highlight the value of human life and call attention to NYC’s ""startling"" numbers, which come from a 2013 report on pregnancy outcomes compiled by the city’s Department of Health and Mental Hygiene’s Bureau of Vital Statistics. The numbers have been widely reported by conservative media outlets, including a National Review article that Meyer emailed to us. ""To be clear, that tweet came from my personal Twitter account and I was speaking as a private citizen,"" Meyer said in an email. ""Happy to defend the stats, though."" Abortions by black women in NYC outpacing births? Figuring out the answer to this question proved rather simple. The first place we went was that 2013 report, the most recent data available, which provides exhaustive breakdowns of birth statistics in New York City. The agency lists pregnancy outcomes by race and ethnicity, as well as by borough, type of birth (live birth, C-section, premature) and health of the mother. According to the report, in 2013 black women accounted for 29,007 terminated pregnancies, representing almost 42 percent of all abortions in the city. That same year, black women in the city gave birth to 24,108 babies. With abortions surpassing live births by nearly 5,000, African American women in the city clearly terminated pregnancies more often than they carried babies to term. Black women terminated pregnancies at a rate of 67.3 per 1,000 women ages 15 to 49, a rate far higher than any other racial or ethnic group. We checked: the statistics were similar the previous year, when African American women in the city had 24,758 births and underwent 31,328 abortions. The numbers for black women in NYC starkly contrasted with women in other racial and ethnic categories. In 2013, births far surpassed abortions for white, Hispanic and Asian/Pacific Islander women. Hispanic women accounted for the second-most abortions in the city with 21,555, but they also had 35,581 live births. Asian women had both the fewest abortions and fewest births, while white women accounted for the most births overall and second-fewest abortions. There was less discrepancy between the number of births and terminated pregnancies for black women statewide. In 2013, black women in New York state gave birth to 36,130 babies and underwent 34,960 abortions, according to the state’s health department. During the previous year, the numbers were almost dead even, with black women accounting for 36,905 births and 36,633 abortions across the state. The numbers are far different for the four biggest cities in Texas. The Texas Department of State Health Services reports births by both county and city, but abortions are only reported by county. We examined the numbers in 2013 for Bexar, Dallas, Harris and Travis Counties, which contain the cities of San Antonio, Dallas, Houston and Austin, respectively. In all four counties, black women had more live births than abortions. The same was  for white women in those counties. For Harris County, which includes Houston, the largest city in Texas and fourth-largest city nationwide, black women had 12,569 live births and 5,515 abortions, while white women accounted for 16,247 births and 2,661 abortions. If you’d like to peruse the numbers for all four counties, we input the data into a Google spreadsheet for easier side-by-side comparison. It’s important to note that abortion access across the state of Texas stands in stark contrast to NYC. Texas currently has 19 operating abortion clinics, but that number would drop to 10 if the U.S. Supreme Court allows the state's contested 2013 law to fully take effect. In contrast, New York state has 80 abortion clinics. Attitudes toward abortion also differ greatly between the two states. Nationally in 2009, black women had abortions far more often than white and Hispanic women, according to data compiled in December 2013 by the National Center for Health Statistics. For some perspective, an online search turned up a 2008 Guttmacher Policy Review article by Susan A. Cohen, a vice president for the Guttmacher Institute, a nonprofit that promotes reproductive health and abortion rights. Cohen, saying the national abortion rate for black women is almost five times the rate for white women, suggested this is greatly explained by higher incidences of unintended pregnancy among African American residents. Higher rates, Cohen wrote, ""reflect the particular difficulties that many women in minority communities face in accessing high-quality contraceptive services and in using their chosen method of birth control consistently and effectively over long periods of time. Moreover, these realities must be seen in a larger context in which significant racial and ethnic disparities persist for a wide range of health outcomes, from diabetes to heart disease to breast and cervical cancer to sexually transmitted infections (STI), including HIV."" In examining the socioeconomic factors behind this phenomena, Cohen disputed the idea that black women are recruited into having more abortions, a sentiment that has been shared by anti-abortion activists and conservative politicians. These issues were also extensively explored last September by Zoe Dutton in a piece for The Atlantic called ""Abortion’s Racial Gap."" GOP leaders have used these statistics to argue against abortion, positing that it disproportionately affects black communities. In August, Republican presidential candidate Ben Carson articulated this stance in relation to Planned Parenthood, claiming during an appearance on Fox News that the organization has contributed to abortion being ""the number one cause of death for black people."" The leading causes of death for black Americans are actually heart disease, cancer and stroke, according to the CDC, but Carson’s rhetoric speaks to the GOP’s broader stance against abortion. The debate over abortion has taken on more fervor in recent years as many states have introduced increased abortion restrictions. Texas has led in this area, in 2013 enacting a law requiring abortion clinics to adhere to the standards of surgical centers and employ doctors with admitting privileges at a hospital within 30 miles of the clinic. In November 2015, the Supreme Court agreed to hear a case challenging the constitutionality of those two provisions as undue burdens on women seeking abortions. Our ruling: A Hillary Clinton declaration that every child should be allowed to live up to his potential prompted a tweet from a spokeswoman for Texas Attorney General Ken Paxton that ""More black babies are aborted in NYC than born."" The tweet from Deputy Press Secretary Cynthia Meyer echoes what has become a talking point among anti-abortion activists, that abortion disproportionately affects the nation’s African American population. Nationally, African American women had a higher rate of abortion than whites, Hispanics or Asians, according to 2013 figures. Even so, black women gave birth more than they terminated pregnancies that year. The same was not  for New York City, where more abortions were recorded for black woman than live births in both 2012 and 2013, the most recent available data. -- The statement is accurate and there's nothing significant missing. Click here for more on the six PolitiFact ratings and how we select facts to check. CLARIFICATION, 4:20 p.m., Dec. 1, 2015: We amended this fact check to clarify that the described 2013 abortion rate for black women related to women aged 15 to 49. This change did not affect our rating."

A: More black babies are aborted in NYC than born.
****
Q: More than 300,000 women around the world were fitted over a decade with implants from the French company Poly Implant Prothese (PIP), and the trial includes 5,000 civil plaintiffs and 300 lawyers. PIP’s founder and long-time chief executive, 73-year-old Jean-Claude Mas, has admitted filling the implants with an unapproved homemade recipe made of industrial-grade silicone gel. Mas and four PIP executives, including the chief financial officer, are charged with aggravated fraud and risk maximum prison terms of five years each, plus fines, for selling the implants around the world from 2001 to 2010, when they were ordered off the market. Mas himself was in court an hour before the start of proceedings, which were mostly taken up with opening day legal arguments. “He bears the enormous weight of this trial on his shoulders,” Mas’s lawyer Yves Haddad said. A vast exhibition building close to PIP’s former premises has been set up as a makeshift courtroom to accommodate the huge crowds expected for the trial, due to last until mid-May. Mas arrived at court under police escort and faced a crush of cameras as the trial began in the southern city of Marseille. “Bastard!” shouted someone in the audience of some 300 victims as Mas appeared live on a giant video screen. Of the more than 5,000 individual lawsuits filed against PIP - once the world’s third-largest supplier of breast implants - and its executives, 220 have come from women outside France. A French woman who alleges that one of her PIP implants began to leak four years after its insertion said outside the courtroom that victims were both scared and angry. “We had foreign bodies put inside us that were flawed ... we could have maybe died from it. The anger is because we were tricked,” said Tomassine Catalano. “It’s frightening.”  Leaving court, Mas sought to defend himself against such charges. “For 30 years I made prostheses,” he told journalists. “I did my best to protect them (women).”  The scandal - revealed after inspectors pursuing a tip-off discovered vats of industrial-grade silicone outside the PIP factory in 2010 - sparked worldwide panic when the government recommended removal of the implants due to an abnormally high rupture rate. Health experts say no link has been established between PIP implants and breast cancer, but in the months after the scandal broke, plastic surgeons around the world reported a flood of removal requests from worried patients. Half the French women with PIP implants, or nearly 15,000, have already opted for removal, whether because of rupture or as a precaution, according to the government. Mas was released in October from eight months in detention following a failure to post bail. He told police that 75 percent of PIP’s implants had contained the homemade gel, which was never been approved by regulators, although he denies it was unsafe. He and the other executives deny the charges. Investigators estimate that Mas’s formula allowed PIP to save nearly $1.6 million in one year alone. When Mas told the court he lived on a modest monthly retirement income of 1,800 euros, hoots erupted from the spectators, prompting the judge to warn that the next person to disrupt proceedings would be thrown out. Minutes before the trial began, a court in Paris rejected a defense request to have the case thrown out. Mas and PIP’s former chief financial officer, Claude Couty are separately implicated in a civil case over fiscal fraud that has yet to reach trial. Mas is also under investigation for manslaughter following a complaint from the mother of a French woman with PIP implants who died of cancer in 2010. ($1 = 0.7616 euros)

A:
Makers of fraudulent breast implants on trial in France.
****